161 related articles for article (PubMed ID: 4236709)
1. [Ocular and cutaneous changes in patients exposed to prolonged treatment with neuroleptic drugs].
Francesconi G; Di Tizio A; Cameo D
Ann Ottalmol Clin Ocul; 1968 Jul; 94(7):835-52. PubMed ID: 4236709
[No Abstract] [Full Text] [Related]
2. Ocular complications of phenothiazines.
Mathalone MB
Trans Ophthalmol Soc U K (1962); 1966; 86():77-88. PubMed ID: 5226613
[No Abstract] [Full Text] [Related]
3. Ocular effects of phenothiazine derivatives and reversibility.
Mathalone MB
Dis Nerv Syst; 1968 Mar; 29(3):Suppl:29-35. PubMed ID: 5672561
[No Abstract] [Full Text] [Related]
4. [Ocular involvement during prolonged treatment with neuroleptics].
Nouri A; Cuendet JF
Schweiz Med Wochenschr; 1968 Oct; 98(43):1708-11. PubMed ID: 4974196
[No Abstract] [Full Text] [Related]
5. Ocular complications of chlorpromazine therapy.
Petrohelos MA; Tricoulis D
Ophthalmologica; 1969; 158 Suppl():469-76. PubMed ID: 4982681
[No Abstract] [Full Text] [Related]
6. [Damage to eyes through conservative therapy].
Kleberger E
Klin Monbl Augenheilkd; 1967; 151(6):777-801. PubMed ID: 4874408
[No Abstract] [Full Text] [Related]
7. Corneal and lens changes after prolonged treatment with chlorpromazine.
Sandvig K
Acta Ophthalmol (Copenh); 1965; 43(5):730-4. PubMed ID: 5898525
[No Abstract] [Full Text] [Related]
8. Incidence and significance of chlorpromazine-induced eye changes.
De Long SL
Dis Nerv Syst; 1968 Mar; 29(3):Suppl:19-22. PubMed ID: 4876741
[No Abstract] [Full Text] [Related]
9. Prognosis of eye complications caused by phenothiazines.
Forrest FM; Snow HL
Dis Nerv Syst; 1968 Mar; 29(3):Suppl:26-8. PubMed ID: 5672560
[No Abstract] [Full Text] [Related]
10. Prolonged treatment of psychotic states. (Over 1600 patients treated continuously 3 to 7 years).
Goldman D
Dis Nerv Syst; 1968 Mar; 29(3):Suppl:51-7. PubMed ID: 4970486
[No Abstract] [Full Text] [Related]
11. Electro-oculography as a diagnostic aid in phenothiazin retinopathy.
Henkes HE
Trans Ophthalmol Soc U K (1962); 1967; 87():285-7. PubMed ID: 5255224
[No Abstract] [Full Text] [Related]
12. Cutaneous and ocular changes associated with the use of chlorpromazine.
Wolf ME; Richer S; Berk MA; Mosnaim AD
Int J Clin Pharmacol Ther Toxicol; 1993 Aug; 31(8):365-7. PubMed ID: 8225679
[TBL] [Abstract][Full Text] [Related]
13. [Priapisms during neuroleptic drug administration (3 cases)].
Bourgeois M
Nouv Presse Med; 1972 Apr; 1(17):1161. PubMed ID: 5035403
[No Abstract] [Full Text] [Related]
14. Ocular changes occurring with prolonged high dose chlorpromazine therapy. Results from a collaborative study.
Prien RF; DeLong SL; Cole JO; Levine J
Arch Gen Psychiatry; 1970 Nov; 23(5):464-8. PubMed ID: 5478574
[No Abstract] [Full Text] [Related]
15. Eye changes following phenothiazine administration.
Garner LL; Wang RI; Hieb E
Wis Med J; 1974 Sep; 73(9):S119-21. PubMed ID: 4153354
[No Abstract] [Full Text] [Related]
16. [Ophthalmologic study of patients receiving psychotropic drugs].
Gol'dovskaia IL
Zh Nevropatol Psikhiatr Im S S Korsakova; 1970 May; 70(5):759-62. PubMed ID: 5311196
[No Abstract] [Full Text] [Related]
17. [Ocular complications in chronic psychiatric patients caused by prolonged use of antipsychotic drugs (author's transl)].
Yang Y
Zhonghua Yan Ke Za Zhi; 1979; 15(3):198-200. PubMed ID: 45367
[No Abstract] [Full Text] [Related]
18. [Choreiform syndromes and durable or irreversible hyperkinesias after prolonged treatment with neuroleptic drugs].
Bergouignan M; Fontanges X; Clèdes J
Ann Med Psychol (Paris); 1966 Jul; 124(2):186-96. PubMed ID: 5967653
[No Abstract] [Full Text] [Related]
19. Some iatrogenic ocular diseases from systemically administered drugs.
Bernstein HN
Int Ophthalmol Clin; 1970; 10(3):553-619. PubMed ID: 4933547
[No Abstract] [Full Text] [Related]
20. [Dolichomegacolon caused by neuroleptic drugs in a psychiatric environment (apropos of 153 cases)].
Bourgeois M; Lefort H; Legros P
Ann Med Psychol (Paris); 1972 Apr; 1(4):556-66. PubMed ID: 5078354
[No Abstract] [Full Text] [Related]
[Next] [New Search]
